Hydroxyprogesterone caproate

DB06789ApprovedSmall moleculeProgestins

Hydroxyprogesterone caproate is a synthetic progestin used for the prevention of spontaneous preterm births in singleton pregnancies in women who have previously had a spontaneous preterm birth. Hydroxyprogesterone caproate is a synthetic steroid hormone that is similar to medroxyprogesterone acetate and megestrol acetate.

Chemical structure of Hydroxyprogesterone caproate
Mechanism
Curator reviewed
Primary indication
Hydroxyprogesterone caproate was previously indicated in the US for the prevention of spontaneous preterm births in singleton pregnancies in women with a history of spontaneous preterm birth.Curator reviewed · 4 structured indications
Formula / weight
C27H40O4 · 428.6041 g/mol (avg)
First approval
United States, 2011
Also known as
17 alpha-hydroxyprogesterone caproate · 17 Hydroxyprogesterone Capronate · 17-alpha hydroxyprogesterone caproate · Hydroxyprogesterone hexanoate
Code names
NSC-17592
Brand names
  • Makena

Resolves to

Clinical / RWD
Structure
InChIKeyDOMWKUIIPQCAJU-LJHIYBGHSA-NSMILES[H][C@@]12CC[C@](OC(=O)CCCCC)(C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
Targets

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
771Drug interactionsStructured to mechanism, not free text
Sign in
24Clinical trialsPhase, status and sponsor resolved per trial
Sign in
4Structured indicationsCondition, population, route and combination as fields, not prose
Sign in
14ContraindicationsEach with its own population and attribute set
Sign in
41Marketed productsAcross 8 countries and 27 labellers
Sign in
14+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Hydroxyprogesterone caproate, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.

Create Account